Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03997474
Title ATL001 in Patients With Metastatic or Recurrent Melanoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Achilles Therapeutics UK Limited
Indications

melanoma

Therapies

ATL001 + Nivolumab

ATL001

Age Groups: adult | senior
Covered Countries


No variant requirements are available.